Source: Journal of the European Academy of Dermatology and Venereology. Unidade: FM
Subjects: MYCOBACTERIUM TUBERCULOSIS (IMUNOLOGIA), TESTES CUTÂNEOS, PSORÍASE, ANTÍGENOS, INFLAMAÇÃO
ABNT
SILVA, L. C. R. et al. Infliximab partially impairs the anti-Mycobacterium tuberculosis immune responses of severe psoriasis patients with positive tuberculin skin-test. Journal of the European Academy of Dermatology and Venereology, v. 26, n. 3, p. 319-324, 2012Tradução . . Disponível em: https://doi.org/10.1111/j.1468-3083.2011.04067.x. Acesso em: 16 nov. 2024.APA
Silva, L. C. R., Geluk, A., Arnone, M., Romiti, R., Franken, K. C. L. M., Duarte, A. J. S., et al. (2012). Infliximab partially impairs the anti-Mycobacterium tuberculosis immune responses of severe psoriasis patients with positive tuberculin skin-test. Journal of the European Academy of Dermatology and Venereology, 26( 3), 319-324. doi:10.1111/j.1468-3083.2011.04067.xNLM
Silva LCR, Geluk A, Arnone M, Romiti R, Franken KCLM, Duarte AJS, Takahashi MDF, Benard G. Infliximab partially impairs the anti-Mycobacterium tuberculosis immune responses of severe psoriasis patients with positive tuberculin skin-test [Internet]. Journal of the European Academy of Dermatology and Venereology. 2012 ; 26( 3): 319-324.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/j.1468-3083.2011.04067.xVancouver
Silva LCR, Geluk A, Arnone M, Romiti R, Franken KCLM, Duarte AJS, Takahashi MDF, Benard G. Infliximab partially impairs the anti-Mycobacterium tuberculosis immune responses of severe psoriasis patients with positive tuberculin skin-test [Internet]. Journal of the European Academy of Dermatology and Venereology. 2012 ; 26( 3): 319-324.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/j.1468-3083.2011.04067.x